Table 2.

Effects of QSYQ on plasma TXB₂ and 6-keto-PGF_1α levels and the ratio of TXB₂/6-keto-PGF_1α in hyperlipidemic rabbits.

Groups	TXB2 (pg/mL)	6-Keto-PGF1α (pg/mL)	TXB2/6-Keto-PGF1α
Control	99.55 ± 7.37	336.84 ± 52.17	0.30 ± 0.04
Model	109.98 ± 6.10*	227.40 ± 44.98**	0.50 ± 0.09**
QSYQ 2.0 g/kg	101.91 ± 8.52#	309.33 ± 45.24##	0.34 ± ±0.06##
QSYQ 1.0 g/kg	100.08 ± 10.33#	254.59 ± 90.44	0.46 ± 0.23
QSYQ 0.5 g/kg	104.21 ± 10.48	255.27 ± 89.87	0.45 ± 0.16
Aspirin	97.39 ± 9.83##	284.58 ± 48.95#	0.34 ± 0.04##
Clopidogrel	104.15 ± 5.42	281.53 ± 27.42#	0.37 ± 0.04#

Data are expressed as mean ± SD (each group, n⩾6).

*P < 0.05, **P < 0.01 compared with control group; ^# P < 0.05, ^## P < 0.01 compared with model group.